New policies to address the global burden of childhood cancers

The Lancet Oncology

Volumn 14, Issue 3, 2013, Pages

  Sullivan, Richard ^a   Kowalczyk, Jerzy R ^b   Agarwal, Bharat ^c   Ladenstein, Ruth ^d   Fitzgerald, Edel ^e   Barr, Ronald ^f   Steliarova Foucher, Eva ^g   Magrath, Ian ^h   Howard, Scott C ⁱ   Kruger, Mariana ^j   Valsecchi, Maria Grazia ^k   Biondi, Andrea ^k   Grundy, Paul ^l   Smith, Malcolm A ^m   Adamson, Peter ⁿ   Vassal, Gilles ^o   Pritchard Jones, Kathy ^p  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c B J WADIA HOSPITAL FOR CHILDREN   (India)

^d ST ANNA CHILDREN S HOSPITAL   (Austria)

^e European Cancer Organisation   (Belgium)

^f MCMASTER UNIVERSITY   (Canada)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j UNIVERSITY OF STELLENBOSCH   (South Africa)

^k UNIVERSITY OF MILANO BICOCCA   (Italy)

^l ALBERTA HEALTH SERVICES   (Canada)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^o INSTITUT GUSTAVE ROUSSY   (France)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CAREER MOBILITY; CHILD HEALTH CARE; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG INDUSTRY; FUNDING; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; LOWEST INCOME GROUP; MEDICAL EDUCATION; PATIENT EDUCATION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REMUNERATION; REVIEW;

ADOLESCENT; CHILD; CLINICAL TRIALS AS TOPIC; DEVELOPED COUNTRIES; GOVERNMENT; HEALTH POLICY; HUMANS; NEOPLASMS; RESEARCH;

EID: 84875389162     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70007-X     Document Type: Review

References (57)

1. World Development Report 1980: poverty and human development; 1980 The World Bank, (accessed Dec 3, 2012). http://wdronline.worldbank.org/worldbank/a/c.html/world_development_repo rt_1980/abstract/WB.0-1950-2834-1.abstract.
2. Globocan 2008: cancer incidence and mortality worldwide WHO, (accessed Jan 2, 2013). http://globocan.iarc.fr.
3. Sullivan R Putting public health back into the global cancer agenda. Ann Oncol 2012, 23:2995-2996.
4. Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA, Pappo AS Challenging issues in pediatric oncology. Nat Rev Clin Oncol 2011, 8:540-549.
5. Chirdan LB, Bode-Thomas F, Chirdan OO Childhood cancers: challenges and strategies for management in developing countries. Afr J Paediatr Surg 2009, 6:126-130.
6. Hesseling PB, Molyneux E, Tchintseme F, et al. Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana. Lancet Oncol 2008, 9:512-513.
7. Barr RD, Feeny D, Furlong W Economic evaluation of treatments for cancer in childhood. Eur J Cancer 2004, 40:1335-1345.
8. Bhakta N, Martiniuk AL, Gupta S, Howard SC. The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi. Arch Dis Child (in press).
9. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five Continents 2007, Vol IX. IARC, Lyon.
10. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cancer in Africa: epidemiology and prevention 2003, Lyon, IARC.
11. Valsecchi MG, Steliarova-Foucher E Cancer registration in developing countries: luxury or necessity?. Lancet Oncol 2008, 9:159-167.
12. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004, 364:2097-2105.
13. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010, 28:2625-2634.
14. Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol 2013, published online Feb 20. http://dx.doi.org/10.1016/S1470-2045(13)70010-X.
15. Magrath I, Steliarova-Foucher E, Epelman S, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol 2013, published online Feb 20. http://dx.doi.org/10.1016/S1470-2045(13)70008-1.
16. Vassal G New drugs for children and adolescents with cancer: the need for novel development pathways. Lancet Oncol 2013, published online Feb 20. http://dx.doi.org/10.1016/S1470-2045(13)70013-5.
17. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006, 355:1572-1582.
18. Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009, 45:992-1005.
19. Hays DM Adult survivors of childhood cancer. Employment and insurance issues in different age groups. Cancer 1993, 71(10 suppl):3306-3309.
20. Houweling TA, Kunst AE Socio-economic inequalities in childhood mortality in low- and middle-income countries: a review of the international evidence. Br Med Bull 2010, 93:7-26.
21. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008, 9:721-729.
22. Pritchard-Jones K Clinical trials for children with cancer in Europe-still a long way from harmonisation: a report from SIOP Europe. Eur J Cancer 2008, 44:2106-2111.
23. Hoey R The EU clinical trials directive: 3 years on. Lancet 2007, 369:1777-1778.
24. Eckhouse S, Sullivan R A survey of public funding of cancer research in the European union. PLoS Med 2006, 3:e267.
25. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F Childhood cancer survival in Europe and the United States. Cancer 2002, 95:1767-1772.
26. Stefan DC, Stones DK The South African paediatric tumour registry-25 years of activity. S Afr Med J 2012, 102:605-606.
27. Usmani GN Pediatric oncology in the third world. Curr Opin Pediatr 2001, 13:1-9.
28. Aber JL, Bennett NG, Conley DC, Li J The effects of poverty on child health and development. Annu Rev Public Health 1997, 18:463-483.
29. Barton MB, Frommer M, Shafiq J Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006, 7:584-595.
30. Kellie SJ, Howard SC Global child health priorities: what role for paediatric oncologists?. Eur J Cancer 2008, 44:2388-2396.
31. Howard SC, Marinoni M, Castillo L, et al. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007, 48:364-369.
32. Marmot M The influence of income on health: views of an epidemiologist. Health Aff (Millwood) 2002, 21:31-46.
33. Wilkinson RG Unhealthy societies. The afflictions of inequality 1997, Routledge, London.
34. Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006, 118:e1600-e1606.
35. Barro RJ, Lee JW International measures of schooling years and schooling quality. Am Econ Rev 1996, 86:218-223.
36. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004, 291:2471-2475.
37. Ahluwalia MS, Carter NG, Chenery HB Growth and poverty in developing countries. J Development Econ 1979, 6:299-341.
38. O'Hare B, Venables J, Southall D Child health in Africa: 2005 a year of hope?. Arch Dis Child 2005, 90:776-781.
39. Starfield B, Shi L Policy relevant determinants of health: an international perspective. Health Policy 2002, 60:201-218.
40. Adamson PC, Blaney SM New approaches to drug development in pediatric oncology. Cancer J 2005, 11:324-330.
41. Pollack IF, Jakacki RI Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol 2011, 7:495-506.
42. Moreno L, Chesler L, Hargrave D, Eccles SA, Pearson AD Preclinical drug development for childhood cancer. Expert Opin Drug Discov 2011, 6:49-64.
43. Downing JR, Wilson RK, Zhang J, et al. The Pediatric Cancer Genome Project. Nat Genet 2012, 44:619-622.
44. Zhao L, Lee J, Mody R, Braun TM The superiority of the time-to-event continual reassessment method to the rolling six design in pediatric oncology phase I trials. Clin Trials 2011, 8:361-369.
45. Brüggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia 2010, 24:521-535. for the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL), International Berlin-Frankfurt-Münster Study Group (I-BFM-SG).
46. Hudson MM, Neglia JP, Woods WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer 2012, 58:334-343.
47. Franco VI, Henkel JM, Miller TL, Lipshultz SE Cardiovascular effects in childhood cancer survivors treated with anthracyclines. Cardiol Res Pract 2011, 2011:1-13.
48. Wells EM, Nageswara Rao AA, Scafidi J, Packer RJ Neurotoxicity of biologically targeted agents in pediatric cancer trials. Pediatr Neurol 2012, 46:212-221.
49. Zwaan CM, Kearns P, Caron H, et al. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium. Cancer Treat Rev 2010, 36:328-334.
50. Pritchard-Jones K, Lewison G, Camporesi S, et al. The state of research into children with cancer across Europe: new policies for a new decade. eCancerMedicalScience 2011, 5:210.
51. Pritchard-Jones K, Dixon-Woods M, Naafs-Wilstra M, Valsecchi MG Improving recruitment to clinical trials for cancer in childhood. Lancet Oncol 2008, 9:392-399.
52. Hearn J, Sullivan R The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK. Eur J Cancer 2007, 43:8-13.
53. Saracci R, Olsen J, Seniori-Costantini A, West R Epidemiology and the planned new Data Protection Directive of the European Union: a symposium report. Public Health 2012, 126:253-255.
54. Thorat C, Xu K, Freeman SN, et al. What the Orphan Drug Act has done lately for children with rare diseases: a 10-year analysis. Pediatrics 2012, 129:516-521.
55. Vassal G Will children with cancer benefit from the new European Paediatric Medicines Regulation?. Eur J Cancer 2009, 45:1535-1546.
56. McGrath P, Phillips E "It is very hard": treatment for childhood lymphoma from the parents' perspective. Issues Compr Pediatr Nurs 2008, 31:37-54.
57. European standards of care for children with cancer Jolanta Kwasniewska's Foundation, European Society of Paediatric Oncology, (accessed Dec 12, 2012). http://www.siope.eu/binarydata.aspx?type=doc/European_Standards_final_20 11(1).pdf.